The expanding demand for specific immunological research and therapeutic design has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using various expression systems, including bacterial hosts, higher cell cultures, and insect